Skip to content
← Late Effects of Treatment for Childhood Cancer (PDQ®)

HEALTH PROFESSIONAL · SOURCE READING

Posttherapy management

Source: Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Survivors with liver dysfunction should be counseled regarding risk-reduction methods to prevent hepatic injury.

Standard recommendations include maintenance of a healthy body weight, abstinence from alcohol use, and immunization against hepatitis A and B viruses.[42]

Source links and citations

In patients with chronic hepatitis, precautions to reduce viral transmission to household and sexual contacts should also be reviewed.

Table 7 summarizes hepatobiliary late effects and the related health screenings.

Source links and citations
Table 7. Hepatobiliary Late Effectsa
Predisposing TherapyHepatic EffectsHealth Screening/Interventions
ALT = alanine aminotransferase; AST = aspartate aminotransferase; HSCT = hematopoietic stem cell transplant.
aAdapted from the Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers.
Methotrexate; mercaptopurine/thioguanine; HSCTHepatic dysfunctionLaboratory tests: ALT, AST, bilirubin levels
Ferritin in those treated with HSCT
Mercaptopurine/thioguanine; HSCTVeno-occlusive disease/sinusoidal obstructive syndromeExamination: scleral icterus, jaundice, ascites, hepatomegaly, splenomegaly
Laboratory tests: ALT, AST, bilirubin, platelet levels
Ferritin in those treated with HSCT
Radiation exposing liver/biliary tract; HSCTHepatic fibrosis/cirrhosis; focal nodular hyperplasiaExamination: jaundice, spider angiomas, palmar erythema, xanthomata, hepatomegaly, splenomegaly
Laboratory tests: ALT, AST, bilirubin levels
Ferritin in those treated with HSCT
Prothrombin time for evaluation of hepatic synthetic function in patients with abnormal liver screening tests
Screen for viral hepatitis in patients with persistently abnormal liver function or any patient transfused before 1993
Gastroenterology/hepatology consultation in patients with persistent liver dysfunction
Hepatitis A and B immunizations in patients lacking immunity
Consider phlebotomy and chelation therapy for iron overload
Radiation exposing liver/biliary tractCholelithiasisHistory: colicky abdominal pain related to fatty food intake, excessive flatulence
Examination: right upper quadrant or epigastric tenderness (acute episode)
Consider gallbladder ultrasonography in patients with chronic abdominal pain
Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice